1. Amphotericin B in liposome revealed fine stability.

2. Conclusion Amphotericin B is an essential antifungal agent for treating ocular fungal infections and its liposomes possesses a good applied perspective.

3. OBJECTIVE To establish a method for determination of amphotericin B in vitreous humor of New Zealand rabbit by HPLC.

4. The results of drug sensitivity showed that amphotericin (AMB) and nystatin (NYS) were the most sensitive and flucytosine (5- Fc ) was the most resistant (54.2%).

5. Amphotericin B overdoses may result in potentially fatal cardiac or cardiorespiratory arrest.

6. Objective : To prepare amphotericin B - polybutylcyanoacrylate - loaded nanoparticle ( AmB - PBCA - NP ) and to assess their ability to pass the blood - brain barrier.

7. For preparation slow release formulation,(http:///amphotericin.html) amphotericin B has been encapsulated with liposome by REV ( Reverse - phase - evaporation ) method .

8. We have evaluated the efficacies of micafungin, amphotericin B, and voriconazole, alone and in double and triple combinations, in a murine model of systemic infection by Scedosporium prolificans.

9. Objective : To prepare amphotericin B - polybutylcyanoacrylate - loaded nanoparticle ( amb-PBCA - NP ) and to assess their ability to pass the blood - brain barrier.

10. Amphotericin B liposome and itraconazole are effective in treating penicilliosis marneffei.

11. Amphotericin B, mycomycin and 5-fluorocytosine were most sensitive to the pathogenic fungi and remain to be the most effective drug to cure deep part infection.

12. Amphotericin B and nystatin, ketoconazole and clotrimazole have been known to have similar antifungal mechanism respectively.

13. Results Amphotericin B is a potent antifungal agent with a broad antifungal spectrum.

14. CONCLUSION: Amphotericin B associated RTA is related to the dosage of amphotericin B and the concurrent medications of nephrotoxic drugs.

15. In conclusion, treatment with amphotericin B and itraconazole has negligible efficacy in CNS aspergillosis.

16. Objective To Study the clinical effect to mycotic keratitis with fluconazole and amphotericin B.

17. AIM: To observe the influence on peripheral blood figure by amphotericin B (AMB) combined with flucytosine (5 FC) in the treatment of the patients with cryptococcus meningitis.

18. Systemic candidiasis requires treatment with systemic antifungal agents such as fluconazole, ketoconazole, itraconazole or amphotericin.

19. To test the effectiveness of his new version of amphotericin B, Wasan sent samples to a laboratory at another university, where it was used to treat mice infected with visceral leishmaniasis.

20. Objective:To investigate the efficacy of fluconazole. Itraconazole and liposome amphotericin B theraphy IFI patients with hematopathy.

21. The drug sensitive test in vitro indicated that itraconazole, amphotericin B and nystatin were highly sensitive, ketoconazole and clotrimazole were low sensitive, fluconazole was resistant.